Yahoo
TSXV - Delayed Quote CAD

Aurora Spine Corporation (ASG.V)

0.1150 -0.0050 (-4.17%)
At close: October 30 at 10:50:30 AM EDT
Chart Range Bar
Loading chart for ASG.V
  • Previous Close 0.1200
  • Open 0.1250
  • Bid 0.1150 x --
  • Ask 0.1300 x --
  • Day's Range 0.1150 - 0.1250
  • 52 Week Range 0.1150 - 0.3250
  • Volume 12,000
  • Avg. Volume 16,833
  • Market Cap (intraday) 8.981M
  • Beta (5Y Monthly) -0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date (est.) Nov 16, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior allograft implant; and SiLO TFX, a titanium implant device for sacroiliac joint fusion. In addition, the company offers Dexa-C, a 3D printed cervical fusion device, which is a porous 3D-printed intervertebral cage that incorporates lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L, a spinal device implanted in the intervertebral body space. Further, it provides TiNano, which offers a product line of lumbar fusion devices. It serves orthopaedic, neuromolecular, pain, and interventional radiological surgeons. The company was founded in 2013 and is headquartered in Toronto, Canada.

www.aurora-spine.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

ASG.V
54.00%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

ASG.V
63.49%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

ASG.V
69.74%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

ASG.V
58.93%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY21
Revenue --
Earnings -368.22k
Profit Margin 0.00%

Q2

FY14

Q3

FY21

-200K
0
200K
400K
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.95%

  • Return on Assets (ttm)

    -6.17%

  • Return on Equity (ttm)

    -36.03%

  • Revenue (ttm)

    17.55M

  • Net Income Avi to Common (ttm)

    -1.22M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    362.63k

  • Total Debt/Equity (mrq)

    123.31%

  • Levered Free Cash Flow (ttm)

    436.43k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: